Pay in 4 interest-free payments of $6.32 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
8.2 Cost-effectiveness and health economic implications The elevated cost of acquisition of GLP-1 receptor agonists convey major challenges for healthcare systems, with yearly treatment expenses between $10,000 and $15,000 USD, markedly surpassing those of conventional diabetic drugs (Kong et al
Highlights of Prescribing Information: Wegovy (semaglutide) tablets, for oral use
Learn more about GLP-1 receptors
Mounjaro, also known as tirzepatide, is a medication used for managing type 2 diabetes
Drug interactions are relatively uncommon with GLP-1 receptor agonists, but their effect on gastric emptying can delay the absorption of oral medications
PMID 40507553
US$ 22.40
:max_bytes(150000):strip_icc()/Health-GettyImages-2112991930-7aba42b37c8641d3a76cb03100b26dda.jpg)
US$ 23.94
US$ 26.77
